3 days popular7 days popular1 month popular3 months popular

New treatment against cognitive dysfunction in chronic cerebral ischemia

Hypoxia-inducible factor-1 and its specific target gene heme oxygenase-1 are involved in acute . However, very few studies have examined in detail the changes in the hypoxia-inducible factor-1/heme oxygenase-1 signaling pathway in chronic .

Prof. and team from China-Japan Friendship Hospital, Jilin University clarified that the hypoxia-inducible factor-1/heme oxygenase-1 signaling pathway is activated following chronic cerebral ischemia and involved in the development of induced by chronic cerebral ischemia. Additionally, cilostazol treatment can decrease hypoxia-inducible factor-1α and heme oxygenase-1 expression levels, and protect against induced by chronic cerebral ischemic injury through an anti-apoptotic mechanism.

These findings are published in the (Vol. 8, No. 19, 2013).

Article: ” Changes of hypoxia-inducible factor-1 signaling and the effect of cilostazol in chronic cerebral ischemia (PDF),” by Chen H, Wei AX, He JT, Yu M, Mang J, Xu ZX.

Neural Regen Res. 2013;8(19):1803-1813.

Source

Neural Regeneration Research